Lipids in Non-insulin Dependent Diabetes: A Case for Treatment?

Panzram G. Mortality and survival in Type 2 (non-insulin dependent) diabetes. Diabetologia 1987; 30: 123–31

Seviour P.W. , Teal T.K. , Richmond W.R. , Elkeles R.S. Serum lipids and macrovascular disease in non-insulin dependent diabetics: a possible new approach to prevention. Diabetic Med 1988; 5: 166–71

Reckless J.P.D. , Betteridge D.J. , Wu P. , Payne B. , Galton D.J. High density and low density lipoproteins and prevalence of vascular disease in diabetes mellitus. BMJ 1978; i: 883–6

Laasko M. , Ronnemaa T. , Pyorala K. , Kallio V. , Puukka P. , Penttila I. Atherosclerotic vascular disease and its risk factors in non-insulin dependent diabetic and non-diabetic subjects in Finland. Diabetes Care 1988; 11: 449–63

Walden C.E. , Knopp R.H. , Wahl P.W. , Beach K.W. , Strandness E. Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med 1984; 311: 953–9

Kannel W.B. , McGee D.L. Diabetes and cardiovascular risk factors. Circulation 1979; 59: 8–13

Janka H.U. Five year incidence of major macrovascular complications in diabetes mellitus. Harm Metab Res 1985; 15(Suppl): 15–19

Rosengren A. , Welin L. , Tsipogianni A. , Wilhelmsen L. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ 1989; 299: 1127–31

Kennedy L. , Washe K. , Hadden D.R. , Weaver J.A. , Buchanan K.D. The effect of intensive dietary therapy on serum high density lipoprotein cholesterol in patients with type 2 (non-insulin dependent) diabetes mellitus: A prospective study. Diabetologia 1982; 23: 24–7

Lalor B.C. , Bhatnagar D. , Winocour P.H. Placebo-controlled trial of the effects of guar gum and metformin on fasting blood glucose and serum lipids in obese Type 2 diabetic patients. Diabetic Med 1990; 7: 242–5

Coulston A.M. , Hollenbeck C.H. , Swislocki A.L.M. , Reaven G.M. Deleterious metabolic effects of high carbohydrate, sucrose containing diets in patients with non-insulin dependent diabetes mellitus. Am J Med 1987; 82: 213–20

Garg A. , Bonanome A. , Grundy S. , Zhang Z. , Ungar R.H. Comparison of a high carbohydrate diet with a high mono-unsaturated fat diet in patients with non-insulin dependent diabetes mellitus. N Engl J Med 1988; 319: 629–34

Lisch H-J , Sailer S. Lipoprotein patterns in diet, sulphonylurea and insulin treated diabetics. Diabetologia 1981; 20: 118–22

Paisey R. , Elkeles R.S. , Hambley J. , Magill P. The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal. Diabetologia 1978; 15: 81–5

Greenfield M.S. , Doberne L. , Rosenthal M. , Vreman H.J. , Reaven G.M. Lipid metabolism in non-insulin dependent diabetes mellitus. Effect of glipizide therapy. Arch Intern Med 1982; 142: 1498–500

Rains S.G.H. , Wilson G.A. , Richmond W.R. , Elkeles R.S. The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes. Diabetic Med 1988; 5: 653–8

Dall'Aglio E. , Strata A. , Reaven G.M. Abnormal lipid metabolism in non-insulin dependent diabetes mellitus. Am J Med 1988; 44: 899–903

Feher M.D. , Rains S.G.H. , Richmond W.R. Beta blockers, lipoproteins and non-insulin dependent diabetes. Postgrad Med J 1988; 64: 926–30

Feher M.D. , Henderson A.D. , Wadsworth J. Alpha-blocker therapy: a possible advance in the treatment of diabetic hypertension. Results of a cross-over study of doxazocin and atenolol in hypertensive non-insulin dependent diabetic subjects. J Hum Hypertens 1990; 4: 571–7

Frick M.H. , Elo O. , Haapa K. Helsinki Heart Study: primary prevention trial with Gemfibrozil in middle-aged men with dyslipidaemia. N Engl J Med 1987; 317: 1237–45

Garg A. , Grundy S. Lovostatin for lowering cholesterol levels in non-insulin dependent diabetes mellitus. N Engl J Med 1988; 318: 81–6